{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:18:20Z","timestamp":1791332300723,"version":"4.3.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbi.2023.09.016","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:10:10Z","timestamp":1695467410000},"page":"319-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cerebrospinal fluid findings in patients with obsessive\u2013compulsive disorder, Tourette syndrome, and PANDAS: A systematic literature review"],"prefix":"10.1016","volume":"115","author":[{"given":"Benjamin","family":"Pankratz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Feige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Runge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Schiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Tebartz van Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-1195","authenticated-orcid":false,"given":"Dominique","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-clinpsy-032813-153713","article-title":"Obsessive-compulsive and related disorders: a critical review of the new diagnostic class","volume":"11","author":"Abramowitz","year":"2015","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0015","doi-asserted-by":"crossref","first-page":"Art. 1","DOI":"10.1001\/archpsyc.1992.01820010009002","article-title":"Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder","volume":"49","author":"Altemus","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0020","article-title":"CSF somatostatin in obsessive-compulsive disorder","volume":"150(3), Art. 3","author":"Altemus","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0010","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1994.03950100042004","article-title":"Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine","volume":"51","author":"Altemus","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.09.016_b0025","doi-asserted-by":"crossref","first-page":"Art. 7","DOI":"10.1016\/S0006-3223(98)00263-7","article-title":"Normal CSF oxytocin and NPY levels in OCD","volume":"45","author":"Altemus","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"6395","key":"10.1016\/j.bbi.2023.09.016_b0030","doi-asserted-by":"crossref","first-page":"eaap8757","DOI":"10.1126\/science.aap8757","article-title":"Analysis of shared heritability in common disorders of the brain","volume":"360","author":"Anttila","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.016_b0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2016.1190867","article-title":"Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition","volume":"18","author":"Bandelow","year":"2017","journal-title":"The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fneur.2019.00732","article-title":"Immunity in gilles de la tourette-syndrome: results from a cerebrospinal fluid study","volume":"10","author":"Baumgaertel","year":"2019","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.bbi.2023.09.016_b0045","doi-asserted-by":"crossref","first-page":"Art. 12","DOI":"10.1038\/npp.2009.77","article-title":"Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder","volume":"34","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2023.09.016_b0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0055","doi-asserted-by":"crossref","first-page":"Art. 1","DOI":"10.1002\/ana.410060109","article-title":"Biogenic amine metabolism in Tourette syndrome","volume":"6","author":"Butler","year":"1979","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12868-016-0313-4","article-title":"Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder","volume":"17","author":"Cappi","year":"2016","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.bbi.2023.09.016_bib475","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbi.2023.09.016_b0065","article-title":"Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania","volume":"112(3), Art. 3","author":"Carpenter","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2023.09.016_b0070","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fpsyt.2020.00564","article-title":"Autoantibody biomarkers for basal ganglia encephalitis in sydenham chorea and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections","volume":"11","author":"Chain","year":"2020","journal-title":"Front. Psych."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.016_b0075","doi-asserted-by":"crossref","first-page":"Art. 9","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS consensus conference","volume":"25","author":"Chang","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.016_b0085","doi-asserted-by":"crossref","first-page":"Art. 9","DOI":"10.1016\/0006-3223(95)00221-9","article-title":"Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette\u2019s syndrome: comparison to obsessive compulsive disorder and normal controls","volume":"39","author":"Chappell","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_bib476","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.bbi.2023.09.016_b0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1017\/S0033291720002895","article-title":"Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases","volume":"52","author":"Endres","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2023.09.016_b0115","article-title":"Immunological causes of obsessive-compulsive disorder: Is it time for the concept of an \u201cautoimmune OCD\u201d subtype?","volume":"1","author":"Endres","year":"2022","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0095","doi-asserted-by":"crossref","unstructured":"Endres, D., Mertens, L., Berger, B., Reisert, M., Runge, K., Nickel, K., Domschke, K., Schiele, M.A., Urbach, H., Venhoff, N., Pr\u00fcss, H., Tebartz van Elst, L. Autoimmune Obsessive-Compulsive Disorder with Novel Anti-Basal Ganglia Antibodies (2022b). Psychother Psychosom. 91(3):214-216. https:\/\/doi: 10.1159\/000522136.","DOI":"10.1159\/000522136"},{"key":"10.1016\/j.bbi.2023.09.016_b0110","article-title":"Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid","volume":"1\u20133","author":"Endres","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0100","doi-asserted-by":"crossref","unstructured":"Endres, D., Domschke, K., Schiele, M.A. (2022d). [Neurobiology of obsessive-compulsive disorder]. Nervenarzt. Jul;93(7):670-677. https:\/\/doi: 10.1007\/s00115-022-01331-0.","DOI":"10.1007\/s00115-022-01331-0"},{"key":"10.1016\/j.bbi.2023.09.016_b0120","article-title":"Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders","volume":"5(3), Art. 3","author":"Fossey","year":"1993","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.bbi.2023.09.016_b0125","doi-asserted-by":"crossref","first-page":"Art. 8","DOI":"10.1016\/0006-3223(95)00197-2","article-title":"Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects","volume":"39","author":"Fossey","year":"1996","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2023.09.016_b0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11920-019-1062-8","article-title":"Obsessive-compulsive disorder: autoimmunity and neuroinflammation","volume":"21","author":"Gerentes","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.bbi.2023.09.016_b0135","doi-asserted-by":"crossref","first-page":"Art. 2","DOI":"10.1002\/mds.870050216","article-title":"Gilles de la Tourette\u2019s syndrome in twins: clinical and neurochemical data","volume":"5","author":"Goetz","year":"1990","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.016_b0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.016_b0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0896-6273(00)00113-6","article-title":"Toward a neurobiology of obsessive-compulsive disorder","volume":"28","author":"Graybiel","year":"2000","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bbi.2023.09.016_b0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpsychires.2008.10.007","article-title":"Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults","volume":"43","author":"Greenberg","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"7650","key":"10.1016\/j.bbi.2023.09.016_b0155","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.bbi.2023.09.016_b0160","doi-asserted-by":"crossref","first-page":"Art. 7","DOI":"10.1016\/j.braindev.2012.10.003","article-title":"Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection","volume":"35","author":"Hachiya","year":"2013","journal-title":"Brain & Development"},{"issue":"8","key":"10.1016\/j.bbi.2023.09.016_b0165","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s004150070130","article-title":"Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls","volume":"247","author":"Haghighi","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2023.09.016_bib470","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.bbi.2023.09.016_b0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1373\/clinchem.2007.099986","article-title":"Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid","volume":"54","author":"Hyland","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbi.2023.09.016_b0175","article-title":"Obsessive-compulsive disorder and serotonin: Is there a connection?","volume":"11","author":"Insel","year":"1985","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2023.09.016_b0180","doi-asserted-by":"crossref","first-page":"Art. 8","DOI":"10.1016\/S0006-3223(96)00174-6","article-title":"Cerebrospinal fluid viral antibodies in obsessive-compulsive disorder in an Indian population","volume":"41","author":"Khanna","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.09.016_b0185","doi-asserted-by":"crossref","first-page":"Art. 5","DOI":"10.1001\/archpsyc.1990.01810170019003","article-title":"Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents","volume":"47","author":"Kruesi","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.016_b0190","doi-asserted-by":"crossref","first-page":"Art. 3","DOI":"10.1016\/0165-1781(90)90044-6","article-title":"CSF somatostatin in childhood psychiatric disorders: a preliminary investigation","volume":"33","author":"Kruesi","year":"1990","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.016_b0200","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1111\/ene.14983","article-title":"Immunity and Gilles de la Tourette syndrome: a systematic review and meta-analysis of evidence for immune implications in Tourette syndrome","volume":"28","author":"Lamothe","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"24","key":"10.1016\/j.bbi.2023.09.016_b0210","doi-asserted-by":"crossref","first-page":"Art. 24","DOI":"10.1016\/0024-3205(88)90575-9","article-title":"Elevated CSF dynorphin A [1-8] in Tourette\u2019s syndrome","volume":"43","author":"Leckman","year":"1988","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bbi.2023.09.016_b0215","doi-asserted-by":"crossref","first-page":"Art. 10","DOI":"10.1001\/archpsyc.1994.03950100030003","article-title":"Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette\u2019s syndrome and healthy controls","volume":"51","author":"Leckman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0220","doi-asserted-by":"crossref","first-page":"Art. 1","DOI":"10.1038\/sj.npp.1380241","article-title":"Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette\u2019s syndrome, and healthy controls","volume":"12","author":"Leckman","year":"1995","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.bbi.2023.09.016_b0225","first-page":"Art. 9","article-title":"Tics and Tourette\u2019s disorder: A 2- to 7-year follow-up of 54 obsessive-compulsive children","volume":"149","author":"Leonard","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00110","article-title":"Reduced brain somatostatin in mood disorders: A common pathophysiological substrate and drug target?","volume":"4","author":"Lin","year":"2013","journal-title":"Front. pharmacol."},{"key":"10.1016\/j.bbi.2023.09.016_b0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fpsyt.2019.00226","article-title":"Systemic lupus erythematosus with isolated psychiatric symptoms and antinuclear antibody detection in the cerebrospinal fluid","volume":"10","author":"L\u00fcngen","year":"2019","journal-title":"Front. Psych."},{"issue":"5","key":"10.1016\/j.bbi.2023.09.016_b0240","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.biopsych.2018.02.1172","article-title":"Dopaminergic disturbances in tourette syndrome: an integrative account","volume":"84","author":"Maia","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.09.016_b0245","doi-asserted-by":"crossref","first-page":"Art. 7","DOI":"10.1038\/mp.2017.215","article-title":"A total-population multigenerational family clustering study of autoimmune diseases in obsessive\u2013compulsive disorder and Tourette\u2019s\/chronic tic disorders","volume":"23","author":"Mataix-Cols","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.bbi.2023.09.016_bib473","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.bbi.2023.09.016_b0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2023.09.016_b0260","doi-asserted-by":"crossref","unstructured":"Mittleman, B. B., Castellanos, F. X., Jacobsen, L. K., Rapoport, J. L., Swedo, S. E., & Shearer, G. M., 1997. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J. Immunol. Res. (Baltimore, Md.: 1950), 159(6), Art. 6.","DOI":"10.4049\/jimmunol.159.6.2994"},{"key":"10.1016\/j.bbi.2023.09.016_bib472","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad-Zadeh","year":"2008","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.bbi.2023.09.016_b0265","doi-asserted-by":"crossref","first-page":"Art. 11","DOI":"10.1002\/mds.20570","article-title":"Paraneoplastic chorea with leukoencephalopathy presenting with obsessive\u2013compulsive and behavioral disorder","volume":"20","author":"Muehlschlegel","year":"2005","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.bbi.2023.09.016_b0270","doi-asserted-by":"crossref","first-page":"Art. 8","DOI":"10.1038\/s41386-020-0671-6","article-title":"Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome","volume":"45","author":"M\u00fcller-Vahl","year":"2020","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2023.09.016_b0275","first-page":"Art. 6","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0280","first-page":"1","article-title":"Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: a retrospective analysis of 54 samples","author":"Pankratz","year":"2022","journal-title":"World J. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2023.09.016_b0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jocrd.2014.06.003","article-title":"The inheritance of tourette disorder: a review","volume":"3","author":"Pauls","year":"2014","journal-title":"Journal of Obsessive-Compulsive and Related Disorders"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.016_b0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.31887\/DCNS.2010.12.2\/dpauls","article-title":"The genetics of obsessive-compulsive disorder: a review","volume":"12","author":"Pauls","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2023.09.016_b0295","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cyto.2017.03.003","article-title":"Case-control, exploratory study of cerebrospinal fluid chemokines\/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers","volume":"96","author":"Pranzatelli","year":"2017","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.016_b0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: Disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2023.09.016_b0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1590\/0004-282X20160044","article-title":"Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. diagnostic patterns not to be missed in neurology and psychiatry","volume":"74","author":"Reiber","year":"2016","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bbi.2023.09.016_b0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/0004-282x20160066","article-title":"Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry","volume":"74","author":"Reiber","year":"2016","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuron.2019.01.046","article-title":"Obsessive-compulsive disorder: puzzles and prospects","volume":"102","author":"Robbins","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0330","doi-asserted-by":"crossref","first-page":"Art. 1","DOI":"10.1038\/nrdp.2016.97","article-title":"Gilles de la Tourette syndrome","volume":"3","author":"Robertson","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbi.2023.09.016_b0335","unstructured":"ROBINS-E Development Group (Higgins J, Morgan R, Rooney A, Taylor K, Thayer K, Silva R, Lemeris C, Akl A, Arroyave W, Bateson T, Berkman N, Demers P, Forastiere F, Glenn B, Hr\u00f3bjartsson A, Kirrane E, LaKind J, Luben T, Lunn R, McAleenan A, McGuinness L, Meerpohl J, Mehta S, Nachman R, Obbagy J, O'Connor A, Radke E, Savovi\u0107 J, Schubauer-Berigan M, Schwingl P, Schunemann H, Shea B, Steenland K, Stewart T, Straif K, Tilling K, Verbeek V, Vermeulen R, Viswanathan M, Zahm S, Sterne J). Risk Of Bias In Non-randomized Studies - of Exposure (ROBINS-E). Launch version, 1 June 2022. https:\/\/www.riskofbias.info\/welcome\/robins-e-tool."},{"issue":"12","key":"10.1016\/j.bbi.2023.09.016_b0340","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1176\/appi.ajp.2016.16080868","article-title":"Effect of a novel NMDA receptor modulator, rapastinel (Formerly GLYX-13), in OCD: proof of concept","volume":"173","author":"Rodriguez","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-007-0758-3","article-title":"In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2\/3 receptor agonist LY404039 in animal models of psychiatric disorders","volume":"193","author":"Rorick-Kehn","year":"2007","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.bbi.2023.09.016_b0350","first-page":"Art.","article-title":"Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis","volume":"61","author":"Scheid","year":"2003","journal-title":"Neur."},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000509910","article-title":"Oxytocin receptor gene DNA methylation: a biomarker of treatment response in obsessive-compulsive disorder?","volume":"90","author":"Schiele","year":"2020","journal-title":"Psychother. Psychosom."},{"issue":"9","key":"10.1016\/j.bbi.2023.09.016_b0360","doi-asserted-by":"crossref","first-page":"Art.","DOI":"10.1038\/s41380-020-01007-8","article-title":"Toward a neurocircuit-based taxonomy to guide treatment of obsessive\u2013compulsive disorder","volume":"26","author":"Shephard","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.09.016_b0365","doi-asserted-by":"crossref","first-page":"Art.","DOI":"10.1038\/nm.2125","article-title":"Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive\u2013like behaviors in mice","volume":"16","author":"Shmelkov","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2023.09.016_b0370","first-page":"177","article-title":"Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome","volume":"35","author":"Singer","year":"1982","journal-title":"Adv. Neurol."},{"issue":"7","key":"10.1016\/j.bbi.2023.09.016_b0375","doi-asserted-by":"crossref","first-page":"Art. 7","DOI":"10.1001\/archneur.1984.04050180078022","article-title":"CSF cholinesterase activity in Gilles de la Tourette\u2019s syndrome","volume":"41","author":"Singer","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbi.2023.09.016_bib468","series-title":"Tourette Syndrome","first-page":"276","article-title":"The neurochemistry of Tourette syndrome","author":"Singer","year":"2013"},{"issue":"3","key":"10.1016\/j.bbi.2023.09.016_b0380","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s12276-021-00580-4","article-title":"The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders","volume":"53","author":"Song","year":"2021","journal-title":"Exp. Mol. Med., Mar"},{"issue":"11","key":"10.1016\/j.bbi.2023.09.016_b0385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.euroneuro.2019.09.001","article-title":"Relationship between obsessive compulsive disorder and cortisol: systematic review and meta-analysis","volume":"29","author":"Sousa-Lima","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.09.016_b0390","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jad.2015.10.061","article-title":"The classification of obsessive-compulsive and related disorders in the ICD-11","volume":"190","author":"Stein","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"02","key":"10.1016\/j.bbi.2023.09.016_b0395","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0665.1000113","article-title":"From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome)","volume":"02","author":"Swedo","year":"2012","journal-title":"Pediatrics & Therapeutics"},{"key":"10.1016\/j.bbi.2023.09.016_b0400","doi-asserted-by":"crossref","unstructured":"Swedo, S. E., Kruesi, M. J., Leonard, H. L., Hamburger, S. D., Cheslow, D. L., Stipetic, M., & Potter, W. Z. (1989). Lack of seasonal variation in pediatric lumbar cerebrospinal fluid neurotransmitter metabolite concentrations. Acta Psychiatrica Scandinavica, 80(6), Art. 6. https:\/\/doi.org\/10.1111\/j.1600-0447.1989.tb03038.x.","DOI":"10.1111\/j.1600-0447.1989.tb03038.x"},{"key":"10.1016\/j.bbi.2023.09.016_b0410","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1176\/ajp.146.2.246","article-title":"High prevalence of obsessive-compulsive symptoms in patients with Sydenham\u2019s chorea","volume":"146","author":"Swedo","year":"1989","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2023.09.016_b0415","doi-asserted-by":"crossref","first-page":"Art. 1","DOI":"10.1001\/archpsyc.1992.01820010029004","article-title":"Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder","volume":"49","author":"Swedo","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2023.09.016_b0405","doi-asserted-by":"crossref","unstructured":"Swedo, S.E., Frankovich, J., Murphy, T.K., 2017. Overview of Treatment of Pediatric Acute-Onset Neuropsychiatric Syndrome. J. Child Adolesc Psychopharmacol. Sep 27 (7), 562\u2013565. https:\/\/doi.org\/10.1089\/cap.2017.0042.","DOI":"10.1089\/cap.2017.0042"},{"issue":"11","key":"10.1016\/j.bbi.2023.09.016_b0420","doi-asserted-by":"crossref","first-page":"Art. 11","DOI":"10.1001\/archpsyc.1980.01780240079009","article-title":"Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects","volume":"37","author":"Thor\u00e9n","year":"1980","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.09.016_b0425","doi-asserted-by":"crossref","first-page":"Art. 7","DOI":"10.1001\/archpsyc.1980.01780200039004","article-title":"Cortisol in the CSF of depressed and suicidal patients","volume":"37","author":"Tr\u00e4skman","year":"1980","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2023.09.016_b0430","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1176\/appi.ajp.2011.09111692","article-title":"The neural circuits that generate tics in tourette\u2019s syndrome","volume":"168","author":"Wang","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"7156","key":"10.1016\/j.bbi.2023.09.016_b0435","doi-asserted-by":"crossref","first-page":"Art.","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.016_b0440","doi-asserted-by":"crossref","first-page":"Art. 2","DOI":"10.1002\/mds.23403","article-title":"Oligoclonal bands in cerebrospinal fluid in patients with Tourette\u2019s syndrome","volume":"26","author":"Wenzel","year":"2011","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"S3","key":"10.1016\/j.bbi.2023.09.016_b0445","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/S1092852900002479","article-title":"Neurobiology of obsessive-compulsive disorder: serotonin and beyond","volume":"12","author":"Westenberg","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbi.2023.09.016_b0450","doi-asserted-by":"crossref","unstructured":"Williams, K. A., Swedo, S. E., Farmer, C. A., Grantz, H., Grant, P. J., D\u2019Souza, P., Hommer, R., Katsovich, L., King, R. A., & Leckman, J. F., 2016. Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections. J. of the American Academy of Child & Adolescent Psychiatry, 55(10), Art. 10. https:\/\/doi.org\/10.1016\/j.jaac.2016.06.017.","DOI":"10.1016\/j.jaac.2016.06.017"},{"key":"10.1016\/j.bbi.2023.09.016_b0455","series-title":"Neurobiology of Cerebrospinal Fluid 2","author":"Wood","year":"2013"},{"key":"10.1016\/j.bbi.2023.09.016_bib466","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/1516-4446-2013-1274","article-title":"Tourette and tic disorders in ICD-11: Standing at the diagnostic crossroads","volume":"36","author":"Woods","year":"2014","journal-title":"Braz. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.09.016_b0460","first-page":"Art. 2","article-title":"A case of Gilles de la Tourette\u2019s syndrome accompanied with alcoholism","volume":"31","author":"Yamane","year":"1977","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"issue":"6","key":"10.1016\/j.bbi.2023.09.016_b0465","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-8986.1996.tb02369.x","article-title":"Autonomic activity in relation to cerebrospinal fluid neurochemistry in obsessive and disruptive children and adolescents","volume":"33","author":"Zahn","year":"1996","journal-title":"Psychophysiol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123002805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123002805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:25:31Z","timestamp":1760171131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159123002805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":97,"alternative-id":["S0889159123002805"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.09.016","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid findings in patients with obsessive\u2013compulsive disorder, Tourette syndrome, and PANDAS: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}